Accepted article
Back to the articles list |
Back to browse issues page
1- Department of Psychology, Ahv.C., Islamic Azad University, Ahvaz, Iran
2- Department of Psychology, Ahv.C., Islamic Azad University, Ahvaz, Iran ,zdashtbzrgi@gmail.com
2- Department of Psychology, Ahv.C., Islamic Azad University, Ahvaz, Iran ,
Abstract: (66 Views)
Objective: Multiple sclerosis (MS) is a chronic neurological condition that is often accompanied by significant emotional and psychological challenges, including profound existential concerns and maladaptive cognitive patterns related to pain and suffering. The present study aimed to evaluate the effects of a logotherapy-based intervention on death anxiety, pain catastrophizing, and dispositional hope among patients with MS.
Methods: This study utilized a randomized controlled trial (RCT) featuring pre- and post-intervention assessments along with a control group. The participants were patients with MS who visited the neurology outpatient clinic at Golestan Hospital in Ahvaz, Iran, in 2025. Thirty eligible patients with MS were selected through convenience sampling and randomly divided into two groups: an intervention group (n=15) and a control group (n=15). Participants in the intervention group took part in ten weekly 60-minute logotherapy sessions. The control group did not receive any additional psychological intervention and continued with their routine medical care during the study period. Measurements were obtained using the Death Anxiety Scale, Pain Catastrophizing Scale, and Adult Hope Scale. Data were analyzed using MANCOVA and follow-up ANCOVA in SPSS version 27.
Results: Compared to the control group, participants in the intervention group demonstrated statistically significant reductions in death anxiety and pain catastrophizing, alongside a substantial increase in hope scores (p<0.001).
Conclusion: The findings indicate that logotherapy is an effective psychological approach for improving mental health outcomes in patients with MS. It successfully reduces dysfunctional cognitive responses to pain and alleviates death-related fears while simultaneously enhancing a sense of meaning and hope in life.
Methods: This study utilized a randomized controlled trial (RCT) featuring pre- and post-intervention assessments along with a control group. The participants were patients with MS who visited the neurology outpatient clinic at Golestan Hospital in Ahvaz, Iran, in 2025. Thirty eligible patients with MS were selected through convenience sampling and randomly divided into two groups: an intervention group (n=15) and a control group (n=15). Participants in the intervention group took part in ten weekly 60-minute logotherapy sessions. The control group did not receive any additional psychological intervention and continued with their routine medical care during the study period. Measurements were obtained using the Death Anxiety Scale, Pain Catastrophizing Scale, and Adult Hope Scale. Data were analyzed using MANCOVA and follow-up ANCOVA in SPSS version 27.
Results: Compared to the control group, participants in the intervention group demonstrated statistically significant reductions in death anxiety and pain catastrophizing, alongside a substantial increase in hope scores (p<0.001).
Conclusion: The findings indicate that logotherapy is an effective psychological approach for improving mental health outcomes in patients with MS. It successfully reduces dysfunctional cognitive responses to pain and alleviates death-related fears while simultaneously enhancing a sense of meaning and hope in life.
Type of Study: Original Research Article |
Subject:
Rehabilitation
Received: 2026/02/1 | Accepted: 2026/05/9
Received: 2026/02/1 | Accepted: 2026/05/9
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
This is an open access article distributed under the terms of the Creative Commons Attribution License (CC-By-NC), which permits use, distribution, and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
Contact Information
